HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Morbidity and mortality of respiratory syncytial virus infection in hospitalized adults: Comparison with seasonal influenza.

AbstractINTRODUCTION:
Respiratory syncytial virus (RSV) is considered a major pathogen that causes acute influenza-like illness. The objective of this study was to compare the clinical outcomes of patients with laboratory-confirmed RSV and patients with influenza infection.
METHODS:
Adults hospitalized in Beilinson Hospital (October 2017-April 2018) with laboratory-confirmed RSV or influenza were included. The primary outcome was the composite of RSV/influenza complications: 30-day mortality, pneumonia, mechanical ventilation, vasopressor support, intensive care unit admission, and myocarditis/encephalitis. Secondary outcomes were individual components of the primary outcome, 90-day mortality, 90-day readmission, and length of hospital stay.
RESULTS:
A total of 639 patients with RSV (n = 113) and influenza (n = 526) were included. The composite primary outcome was 21.4% (136/633), and was higher in RSV patients (30% (34/113) vs 19% (102/526), p = 0.002). Pneumonia was more common in RSV patients (21.2% (24/113) vs 9.1% (48/526), p = 0.001). On multivariable analysis, hypoalbuminemia (odds ratio (OR) 3.3, 95% confidence interval (CI) 2.1-5.3, p < 0.001), reduced room-air saturation (OR 1.1, 95% CI 1.02-1.1, p = 0.001), and infection with RSV (OR 1.67, 95% CI 1.01-2.76, p = 0.046) were predictors of complications.
CONCLUSIONS:
RSV infection in hospitalized adults resulted in serious respiratory illness with complications that are comparable to those caused by influenza.
AuthorsAlaa Atamna, Tanya Babich, Dafi Froimovici, Dafna Yahav, Nadav Sorek, Haim Ben-Zvi, Leonard Leibovici, Jihad Bishara, Tomer Avni
JournalInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases (Int J Infect Dis) Vol. 103 Pg. 489-493 (Feb 2021) ISSN: 1878-3511 [Electronic] Canada
PMID33249288 (Publication Type: Journal Article)
CopyrightCopyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.
Topics
  • Aged
  • Aged, 80 and over
  • Female
  • Hospitalization
  • Humans
  • Influenza, Human (epidemiology, mortality, pathology, virology)
  • Inpatients
  • Male
  • Middle Aged
  • Morbidity
  • Respiratory Syncytial Virus Infections (epidemiology, mortality, pathology, virology)
  • Respiratory Syncytial Virus, Human (isolation & purification)
  • Retrospective Studies
  • Seasons

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: